Article ID Journal Published Year Pages File Type
9385710 Respiratory Medicine 2005 10 Pages PDF
Abstract
In this study, formoterol 9 μg bid via Turbuhaler® as maintenance therapy, with either formoterol or terbutaline as rescue medication, provided sustained improvements in lung function and COPD symptoms. Both formoterol regimens were well tolerated with no differences in adverse events or electrocardiogram profiles.
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Authors
, , , , , , ,